Esperion Therapeutics, Inc.ESPRNASDAQ
LOADING
|||
Debt to Assets Over Time
Trending lower, above historical average, strong compound growth.
Left:
||||
Debt-to-assets ratio
Latest
1.72
↑ 159% above average
Average (9y)
0.66
Historical baseline
Range
High:2.63
Low:0.00
CAGR
+70.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 1.72 | -34.6% |
| 2023 | 2.63 | +149.8% |
| 2022 | 1.05 | +54.3% |
| 2021 | 0.68 | +29.9% |
| 2020 | 0.52 | +7101.1% |
| 2019 | 0.01 | - |
| 2018 | 0.00 | -100.0% |
| 2017 | 0.00 | -66.2% |
| 2016 | 0.01 | -23.3% |
| 2015 | 0.01 | - |